Deine Seite wird geladen …
International Consensus Statement
Inhalt auf Englisch
Osler antwortet aus dieser Bibliothek und nennt zu jeder Aussage die Leitlinie dahinter.
Researchers and clinicians worldwide share concerns that many youngsters with attention-deficit/hyperactivity disorder (ADHD) and/or disruptive behaviour disorders (DBDs) do not receive appropriate treatment despite availability of effective therapies. At the request of Johnson and Johnson (sponsor), 11 international experts in child and adolescent psychiatry were selected by Professor Stan Kutcher (chair) to address these concerns. This paper describes the experts' consensus conclusions, including treatment practice suggestions for physicians involved in the early treatment of youngsters with ADHD (or hyperkinetic disorder, in countries preferring this classification) and/or DBDs internationally: suggested first-line treatment for ADHD without comorbidity is psychostimulant medication aided by psychosocial intervention. For ADHD with comorbid conduct disorder (CD), psychosocial intervention combined with pharmacotherapy is suggested. For primary CD, suggested first-line treatment is psychosocial intervention, with pharmacotherapy considered as an 'add-on' when aggression/impulsivity is marked and persistent. Pharmacotherapy requires careful titration; full-day coverage is the suggested goal. Regular long-term follow-up is recommended.
Veröffentlicht von European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2004. Die Leitlinie selbst findest du bei der hier verlinkten Quelle.
Prognia fasst diese Leitlinie zum Nachschlagen und Lernen zusammen. Das ist keine medizinische Beratung. Prüfe immer die offizielle Leitlinie und die aktuellen lokalen Standards, bevor du danach handelst.
